196 related articles for article (PubMed ID: 1340438)
1. Vasodilators in persistent pulmonary hypertension of the newborn: a need for optimal appraisal of efficacy.
Gouyon JB; Françoise M
Dev Pharmacol Ther; 1992; 19(2-3):62-8. PubMed ID: 1340438
[TBL] [Abstract][Full Text] [Related]
2. Persistent pulmonary hypertension of the newborn: experience in a single institution.
Hsieh WS; Yang PH; Fu RH
Acta Paediatr Taiwan; 2001; 42(2):94-100. PubMed ID: 11355072
[TBL] [Abstract][Full Text] [Related]
3. Pharmacologic therapy of persistent pulmonary hypertension of the newborn.
Weinberger B; Weiss K; Heck DE; Laskin DL; Laskin JD
Pharmacol Ther; 2001 Jan; 89(1):67-79. PubMed ID: 11316514
[TBL] [Abstract][Full Text] [Related]
4. Inhaled prostacyclin for term infants with persistent pulmonary hypertension refractory to inhaled nitric oxide.
Kelly LK; Porta NF; Goodman DM; Carroll CL; Steinhorn RH
J Pediatr; 2002 Dec; 141(6):830-2. PubMed ID: 12461501
[TBL] [Abstract][Full Text] [Related]
5. Treatment of Persistent Pulmonary Hypertension of the Newborn: Use of Pulmonary Vasodilators in Term Neonates.
Luecke C; McPherson C
Neonatal Netw; 2017 May; 36(3):160-168. PubMed ID: 28494828
[TBL] [Abstract][Full Text] [Related]
6. Cerebral blood flow during treatment for pulmonary hypertension.
Kusuda S; Shishida N; Miyagi N; Hirabayashi M; Kim TJ
Arch Dis Child Fetal Neonatal Ed; 1999 Jan; 80(1):F30-3. PubMed ID: 10325808
[TBL] [Abstract][Full Text] [Related]
7. Persistent pulmonary hypertension of the newborn.
Mandell E; Kinsella JP; Abman SH
Pediatr Pulmonol; 2021 Mar; 56(3):661-669. PubMed ID: 32930508
[TBL] [Abstract][Full Text] [Related]
8. [Prostacyclin in the treatment of persistent fetal circulation syndrome].
Messner H; Gios G; Gentili L; Mascheroni D; Pedron C; Pedron E; Mengarda G
Pediatr Med Chir; 1992; 14(3-6 Suppl):57-60. PubMed ID: 1589338
[TBL] [Abstract][Full Text] [Related]
9. Endotracheal tolazoline administration in neonates with persistent pulmonary hypertension.
Parida SK; Baker S; Kuhn R; Desai N; Pauly TH
J Perinatol; 1997; 17(6):461-4. PubMed ID: 9447533
[TBL] [Abstract][Full Text] [Related]
10. The use of sildenafil in the treatment of persistent pulmonary hypertension of the newborn: a review of the literature.
Iacovidou N; Syggelou A; Fanos V; Xanthos T
Curr Pharm Des; 2012; 18(21):3034-45. PubMed ID: 22564297
[TBL] [Abstract][Full Text] [Related]
11. Life-threatening PPHN refractory to nitric oxide: proposal for a rational therapeutic algorithm.
Fortas F; Di Nardo M; Yousef N; Humbert M; De Luca D
Eur J Pediatr; 2021 Aug; 180(8):2379-2387. PubMed ID: 34091748
[TBL] [Abstract][Full Text] [Related]
12. Persistent pulmonary hypertension in a very low birthweight preterm infant.
Watchko JF
Clin Pediatr (Phila); 1985 Oct; 24(10):592-5. PubMed ID: 4040838
[TBL] [Abstract][Full Text] [Related]
13. Inhaled nitric oxide therapy for persistent pulmonary hypertension of the newborn.
Fineman JR; Zwass MS
Acta Paediatr Jpn; 1995 Aug; 37(4):425-30. PubMed ID: 7572140
[TBL] [Abstract][Full Text] [Related]
14. Persistent pulmonary hypertension of the newborn successfully treated with beraprost sodium: a retrospective chart review.
Nakwan N; Nakwan N; Wannaro J
Neonatology; 2011; 99(1):32-7. PubMed ID: 20588068
[TBL] [Abstract][Full Text] [Related]
15. [The prevalence and characteristics of persistent pulmonary hypertension of the newborn. A multicenter study. The Study Group of the Società Italiana di Cardiologia Pediatrica (SICP)].
Favilli S; De Simone L; Pollini I; Bettuzzi MG; Cianfrini D; Crepaz R; Santillo V; Trevisanuto D; Vignati G; Manetti A
G Ital Cardiol; 1998 Nov; 28(11):1247-52. PubMed ID: 9866802
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary Vasodilator Therapy in Persistent Pulmonary Hypertension of the Newborn.
Sharma M; Callan E; Konduri GG
Clin Perinatol; 2022 Mar; 49(1):103-125. PubMed ID: 35209994
[TBL] [Abstract][Full Text] [Related]
17. Nitric oxide in the management of persistent pulmonary hypertension of the newborn--an unusual cause of failure.
Jerwood DC; Stokes MA
Paediatr Anaesth; 1995; 5(3):193-5. PubMed ID: 7489441
[TBL] [Abstract][Full Text] [Related]
18. Current and future therapeutic options for persistent pulmonary hypertension in the newborn.
Rao S; Bartle D; Patole S
Expert Rev Cardiovasc Ther; 2010 Jun; 8(6):845-62. PubMed ID: 20528642
[TBL] [Abstract][Full Text] [Related]
19. Intravenous epoprostenol improves oxygenation index in patients with persistent pulmonary hypertension of the newborn refractory to nitric oxide.
Ahmad KA; Banales J; Henderson CL; Ramos SE; Brandt KM; Powers GC
J Perinatol; 2018 Sep; 38(9):1212-1219. PubMed ID: 30046179
[TBL] [Abstract][Full Text] [Related]
20. Effect of early adjunctive use of oral sildenafil and inhaled nitric oxide on the outcome of pulmonary hypertension in newborn infants. A feasibility study.
Al Omar S; Salama H; Al Hail M; Al Rifai H; Bunahia M; El Kasem W; Siddiqui FJ; Dilawar M; Yassin H; Masud F; Mohamed A; Mansour A
J Neonatal Perinatal Med; 2016 Sep; 9(3):251-9. PubMed ID: 27589542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
